About U-CAN

Since 2010, U-CAN has built an infrastructure for the collection and biobanking of standardised frozen tissue and blood samples from patients with prioritised cancer diagnoses with the aim of covering 30% of Sweden’s cancer patients. The U-CAN biobank contains patients samples that are taken before, during and after cancer therapy together with comprehensive patients data and radiological images.
U-CAN opens new possibilities in translational cancer research and offers academic scientists and companies research collaborations covering longitudinal information and biobanked material. The unique material can be used to develop methods to fine tune diagnoses and treatment regimes, to identify novel disease targets and biomarkers, and to analyse treatment efficacy and side-effect profiles.
For more information about U-CAN, please go to: www.u-can.uu.se